Hi all,
We are pleased to share our September 2021 investor newsletter, which has been released to the ASX today.
Our latest edition includes an update from our President and CEO Bob Proulx on the Company’s current progress in our Phase 1 trial, and further clinical research for other indications.
Also included in this edition is a Q&A with Dr Jane Fox - Principal Investigator of the MagSense’s HER2 Breast Cancer clinical study, insights into our collaborative research program with Patrys Limited for brain cancer, and an introduction to our new Chief Development Officer.
You can read the newsletter here.
Ann: Imagion Biosystems September 2021 Investor Newsletter, page-14
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
